← Eichor
Study identifier: NCT06141798 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

Condition: Age Problem · Dialysis; Complications · Frailty  ·  Sponsor: Soonchunhyang University Hospital

PhaseNA
Planned participants428
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersNo

About this study

As Korea is becoming a super-aged society, the number of elderly patients with end-stage kidney disease (ESKD) is expected to increase rapidly. Therefore, the burden on Korean society will also increase. Thrice-weekly hemodialysis is standard for renal replacement therapy. However, this regimen has not been validated for elderly ESKD patients with residual renal function. Elderly patients can have multiple comorbidities such as hypertension, diabetes, cardiovascular disease, and impaired physical activity. Frequent hemodialysis could provoke falls, hypotension, and cognitive impairment. Previous reports have suggested the potential benefit of twice-weekly hemodialysis with incremental increases in frequency when residual renal function decreases. In addition, twice-weekly hemodialysis decreases hospitalization rates in frail patients. Therefore, the investigators hypothesized initiating renal replacement therapy with twice-weekly hemodialysis decreases the hopsitalizatoin rates compared with conventional thrice-weekly hemodialysis in elderly ESRD patients with residual renal function. This study is a pragmatic randomized clinical trial, multicenter study. Study subjects are incident ESRD patients (\>= 60 years old, n=428) with residual urine volume ( \> 500 mL/day) and follow up up to 2 years. Twice-weekly hemodialysis could be incremented according to clinical situations such as volume overload, hyperkalemia and uremic symptom. Primary outcome of this study is hospitalizat…

This description comes directly from the study's public registry record.

Talk to the study team

Soon Hyo Kwon, MD  ·  +8227099177  ·  ksoonhyo@schmc.ac.kr

Sook Kim  ·  +8227099177  ·  himoomin@naver.com

Always discuss trial participation with your own doctor first.

Locations (7)

Soonchunhyang University Hospital BucheonBucheon-si, South KoreaRecruiting
Hallym University Medical Center- ChuncheonChuncheon, South KoreaCompleted
Soonchunhyang University Seoul HospitalSeoul, South KoreaActive Not Recruiting
Kangbuk Samsung Medical CenterSeoul, South KoreaCompleted
Koera University Guro HospitalSeoul, South KoreaCompleted
The Catholic University of Korea, Yeouido St. Mary's HospitalSeoul, South KoreaCompleted
Yonsei University, Wonju Severance Christian HospitalWŏnju, South KoreaCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06141798